A Debnath, R Mazumder, RK Singh… - International Journal of …, 2024 - Elsevier
The development of targeted therapies for breast cancer, particularly those focusing on
cyclin-dependent kinases 4/6 (CDK4/6), has significantly improved patient outcomes …